SOLD OUT – FRCPath Part 2 Surgical Course – 8th – 21st January 2020 WITH MICROSCOPE HIRE

Course Fee : £950

Course Overview:

This is a 2 Week Surgical Revision Course preparing trainees for the Histopathology FRCPath Part 2 Examination.

Course Objectives:

  • Designed to prepare trainees for the part 2 surgical pathology examination in histopathology
  • To provide an approach to the part 2 examination
  • To cover common exam cases
  • Trainers have been selected for their expertise within their disciplines, both in their clinical acumen but also their teaching skills
  • Format of the course is intense and demanding but also rewarding

Key Features of the Course:

  • Exam orientated Course
  • Experienced Consultants lecturing, with a pedigree of teaching
  • Surgical and Cytology Mock Tests
  • Opportunity to address and discuss difficult cases
  • Management Lecture
  • Feedback from Speakers

Target Audience:

  • Pathology trainees preparing for Histopathology FRCPath Part 2 Surgical examination

Dates of Courses:

28th August - 10th September 2019 (Sold Out)

8th - 21st January 2020

27th August - 9th September 2020

Course Fees:

£950 includes hire of a microscope for use on this course. Should you have your own microscope, please click here to be taken to the course only booking page. There is no lunch provided with this course.

Limited Places:

A maximum of 30 delegates can attend

Course Sponsor: Leica Biosystems 

Dr Abbie Pugh – Course Director

Dr Abbie Pugh is a Specialist Registrar at New Cross Hospital, Wolverhampton in the West Midlands Deanery. She graduated from the University Of Wales College Of Medicine in 2006 and commenced histopathology speciality training in 2008 after completing her Foundation Studies in North Wales. She is actively involved in teaching medical undergraduates at the University of Birmingham and is a School STEM Ambassador. She is currently the Chair of the Trainee Members’ Group of the Association of Clinical Pathologists.

Dr Lia Menasce

Consultant Histopathologist, MD, PhD FRCPath

Dr Abeer M Shaaban

Dr Shaaban is a Consultant Breast Pathologist/ Honorary Senior Lecturer Department of Histopathology and Molecular Pathology, St James’s University Hospital. Dr Shaaban is a specialist breast pathologist who works in a large tertiary referral centre and a regional centre for HER2 immunohistochemistry and FISH testing.
Dr Shaaban did a PhD on the analysis of morphological and molecular markers associated with breast neoplasia progression and published with the late Professor JP Sloane, one of the pioneers in the field of breast pathology. Her areas of interest include diagnostic and prognostic markers in breast cancer, in particular estrogen receptors, columnar cell lesions and male breast cancer. She produced many research articles, reviews and book chapters. Dr Shaaban is a committee member of the Pathological Society of Great Britain and Ireland and an active member of its Educational Subcommittee, member of the NCRI Breast Clinical Studies Group and its Translational Research Subgroup.

Dr Judy Wyatt

Dr Judy Wyatt graduated in Bristol in 1979, and trained in Histopathology in Yorkshire in the 1980’s. She has worked as Consultant with a special interest in liver and GI pathology in Leeds since 1987, following 3 months at the Royal Free studying liver pathology with Professor Scheuer. She has been the organiser of the National Liver Histopathology EQA scheme since 2004, and the RCPath sub-specialty representative for liver histopathology since 2007. She has a long standing interest in training, and was Histopathology Training Programme Director in Yorkshire from 2005 – 2010.

Dr Jonathan Shanks

Dr Jonathan H Shanks qualified MB ChB (Hons) from Manchester University in 1987, having also completed an intercalated BSc (Hons) in anatomy in 1984. Following six years of training (five in histopathology) at the Royal Victoria Hospital, Belfast he joined the North West histopathology training rotation, working for several years at various hospitals Manchester and Lancashire. During this time he completed his MD thesis, through Queen’s University, Belfast in 2004. He gained the MRCPath (now FRCPath) in 1995. In addition to receiving broad training in histopathology, he developed a special interest in nephropathology during training.
Shortly after appointment to the Christie Hospital, Manchester in 1997 he undertook a sabbatical at the Mayo Clinic, Rochester with Dr David G Bostwick in urological pathology. Although not a monospecialist, his main area of interest for more than 13 years has been urological pathology. He is a member of the British Association of Urological Pathologists and a fellow of the International Society of Urological Pathologists. He has published more than 70 papers and review articles, a many of which are in the field of urological pathology. He has delivered multiple invited presentations to a wide variety of regional, national and several international meetings as well as slide seminars at regional and national meetings.

Dr Neil Sahasrabudhe

Dr Sahasrabudhe completed his undergraduate medical training in Pune, India. He then went on to complete a MD in Pathology from the University of Pune, where he was awarded a Gold Medal. He worked as a Lecturer at the same University for a further 4 years. In 2004, Dr Sahasrabudhe came to the U.K. and commenced Specialist Histopathology training in the North Western Deanery between 2004 and 2008. He was appointed as a Consultant Histopathologist in Royal Blackburn Hospital in February 2008.
Dr Sahasrabudhe is a General Histopathologist and Cytopathologist. He has a special interest in haemato-lymphoid pathology. He has several publications to his credit; he also enjoys and is actively involved in post-graduate teaching.

Dr Patrick Shenjere

Consultant Soft Tissue Pathologist, Christie Cancer Hospital, Manchester

Dr Will Merchant

Dr Merchant is a senior dermatopathologist working in the department of Histopathology at St. James’s University Hospital. Dr Merchant has a thriving referral practice and has regional and national recognition. He is also an examiner for the Diploma in Dermatopathology of the Royal College of Pathologists.

Dr Anu Roy

Consultant Renal Pathologist, Hull Royal Infirmary, Hull

Dr Leena Joseph

After obtaining her MD in Pathology from India, she came to Manchester UK, where she had further training and obtained her FRC Path. She initially started her consultant job at Macclesfield District hospital, and then later joined the pathology department at University hospitals South Manchester NHS Foundation Trust. Dr. Joseph has been the lead for dermatopathology at UHSM since 2007 and has a special interest in the pathology of skin cancers. Her other areas of subspecialisation are in Cardiothoracic pathology and breast pathology.

Dr Durgesh Rana

Dr Durgesh Rana is the clinical lead of non-gynaecology services at Manchester Cytology Centre with a particular interest in respiratory cytology. She received her MBBS in 1988 from Rajasthan University, India and went on to get her MD in pathology in 1993 from Bombay University. She moved to St James Hospital, Dublin as a specialist registrar in 1997, gained the RCPath diploma in Cytopathology 2 years later, completed the MRCPath in 2002, and became a full member of the RCPath in 2003. Since that time she has worked as a specialist consultant cytopathologist at the Manchester Cytology Centre, Manchester Royal Infirmary.
Durgesh has an active interest in, and reports on, both cervical cytology and a wide range of non-gynaecological cytology with publications in both areas. She has given numerous workshops and lectured at a variety of cytology training schools across the UK, as well as at national and international conferences. As one of the NW regional trainers involved in the national conversion to LBC cervical cytology she gave extensive training in both SurePath and ThinPrep systems. Her recent activities include teaching of undergraduates, screening staff, BMS, pathology trainees, and other consultants, membership of the BSCC council and lead for non-gynaecological service development at the Manchester Cytology Centre.